The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
Muhammad Umair Mushtaq (@KUMedCenter) discusses outcomes of alloHSCT in TP53-mutated AML and MDS: 👉http://ow.ly/I7PX50J8F9s👈 @ASTCT @CIBMTR #Tandem22 #MDSsm #LeuSM #AMLsm #Leukemia #MyelodysplasticSyndromes #HemOnc #BMTsm
2 weeks to go until #ASCO22! 🎉 We’re counting down to one of the biggest oncology congresses of the year – stay tuned with VJHemOnc for the highlights in hematological cancers! 👩⚕️👨⚕️ @ASCO
Pieter Sonneveld (@ErasmusMC) shares some insights on how to approach myeloma patients with high-risk cytogenetics at #COMy22. Watch now: 🎥: http://ow.ly/LKlF50J8EW3 @COMyCongress #MMsm #HemOnc #Myeloma
Day 3 highlights from #COMy22 - we had such a lovely time! Our expert-led interviews are now live on: 👉http://ow.ly/NxEa50JayAm👈 @COMyCongress @Mohty_EBMT @SagarLonialMD #MMsm #Myeloma #HemOnc
We're pleased to bring you our latest podcast! Join leading experts as they discuss the impact of artificial intelligence and machine learning in the treatment of MDS: 🎧: http://ow.ly/1Akr50J8EBm #MDSsm #MyelodysplasticSyndromes
Explore our coverage of real-world data across a spectrum of hematological diseases.
The latest results from the key trials at ASH 2020.
Watch experts explain the data from cutting-edge research.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter